Endo to Acquire NuPathe for $2.85/Share in Cash
December 16, 2013 at 07:01 AM EST
Endo Health Solutions (Nasdaq: ENDP ) today announced it has entered into a definitive agreement under which Endo will acquire NuPathe Inc. (Nasdaq: PATH ) for $2.85 per share in cash, or approximately $105 million. In addition to the upfront cash payment, NuPathe shareholders will receive rights to